Form 4: Bioventus Inc. Executive Katrina J. Church Reports Sale of Shares to Cover Taxes

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., sold 2,559 shares of Class A Common Stock to cover taxes upon vesting of restricted stock units.

Summary

• On June 21, 2024, Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., sold 2,559 shares of Class A Common Stock.
• The sale was executed at a price of $5.57 per share.
• The transaction was made pursuant to a standing 10b5-1 instruction adopted on June 20, 2023.
• The shares were sold to cover taxes upon the vesting of restricted stock units on June 20, 2024.
• Following the transaction, Church beneficially owns 41,199 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (stock sale to cover taxes) by an executive, which is neither particularly positive nor negative. The use of a 10b5-1 plan suggests proper governance.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations arising from the vesting of stock-based compensation. These transactions are often pre-planned under 10b5-1 trading plans to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time.
• Upon vesting, these units are subject to income tax, and executives commonly sell a portion of the shares to cover these taxes.
• The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
• Comparable companies in the medical device industry also utilize stock-based compensation and 10b5-1 plans for their executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates